TMRW Life Sciences
New York
About TMRW Life Sciences
TMRW is a life sciences technology company setting new standards for transparency, safety, and accountability in IVF and cell management. TMRW's platform, the world's first automated cryo-management for eggs and embryos, provides a complete digital chain of custody fully integrated with a robotic storage and monitoring solution. This is in contrast to the manual and analog methods that have gone unchanged throughout the history of IVF. With TMRW's platform, clinics significantly reduce the chances of potentially devastating errors. The TMRW team includes celebrated innovators in fertility, embryology, cryo-management, automation, software development, and robotics. TMRW is founded by Joshua Abram, Alan Murray, and Dr. Jeffrey Port in 2018 and is based in New York, New York.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $181.7M
- Funding stage: Late Stage Venture
- Last round: Series D (Jul 2024)
- Website: tmrw.org
- Phone: +1 866 733 8679
Industries & Categories
Biotechnology, Health Care, Life Science, Software
Social Profiles
Canonical: https://fsome.com/organization/tmrw-life-sciences-54684 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.